Recurrent pregnancy loss
- Approach to a problem
Losing several pregnancies is painful and frightening. A short, focused workup finds the treatable causes, and even without one most couples have hope.
See it in 3D: Body of uterus · Fundus of uterus · Endometrium · Cervix
What it is
Recurrent pregnancy loss (RPL) is defined in the United States as two or more failed clinical pregnancies confirmed by ultrasound or histology, and in the United Kingdom as three or more consecutive early losses. About 2% of women have two consecutive losses. Up to half of couples have no cause found. The causes that are looked for are antiphospholipid syndrome (APS), uterine anomalies (especially a septate uterus) and acquired cavity problems, a balanced chromosomal rearrangement in either parent, and poorly controlled diabetes or thyroid disease; older maternal age, obesity and smoking add risk. A single sporadic loss is most often due to a chromosomally abnormal embryo, a chance event that becomes commoner with age. RPL is primary if there has never been a live birth and secondary if there has.
Red flags
- Losses in the second trimester: think cervical insufficiency, uterine anomaly or APS.
- A history of venous or arterial thrombosis, lupus, or severe early preeclampsia: test for APS.
- A loss with a fetal chromosomal rearrangement found on testing: karyotype both parents.
- Older women: time matters, so investigate promptly and consider fertility referral.
Step-by-step approach
- Confirm what counts: clinical pregnancies, how many, consecutive or not, and at what gestation each was lost.
- History: thrombosis, autoimmune disease, diabetes, thyroid symptoms, smoking, alcohol, weight and family history.
- APS: lupus anticoagulant, anticardiolipin and anti-beta-2-glycoprotein I antibodies; repeat any positive at least 12 weeks later.
- Uterine cavity: three-dimensional ultrasound, saline sonohysterography or hysteroscopy.
- Metabolic: thyroid function and HbA1c or fasting glucose.
- Chromosomes: test the tissue of the next loss; karyotype both parents if it shows an unbalanced rearrangement or cannot be tested.
- Treat what is found: aspirin with heparin for APS, hysteroscopic removal of a septum, control of diabetes or thyroid disease, stop smoking.
- No cause: offer early ultrasound and supportive care in the next pregnancy, and avoid unproven treatments.
The causes of recurrent loss that are worth finding
| Cause | Clue | Test | What helps |
|---|---|---|---|
| Antiphospholipid syndrome | Thrombosis, lupus, early severe preeclampsia | Antiphospholipid antibodies, positive twice 12 weeks apart | Low-dose aspirin plus heparin in pregnancy |
| Uterine anomaly (septate uterus) | Losses, malpresentation, second-trimester loss | 3D ultrasound, hysteroscopy | Hysteroscopic resection of the septum |
| Parental balanced rearrangement | Abnormal fetal karyotype, family history | Karyotype of both parents | Genetic counselling; testing of embryos is an option |
| Diabetes or thyroid disease | Symptoms, high HbA1c | HbA1c, TSH | Control before the next pregnancy |
| Unexplained (up to half) | All tests normal | None further | Early scans and support; good outlook |
Keys to the differential
- Painless dilation of the cervix with a second-trimester loss is cervical insufficiency, a different problem with a different treatment.
- Inherited thrombophilias are only weakly linked to early loss; routine testing does not change management.
- A single positive antiphospholipid test is not APS: infections cause transient antibodies, so persistence is required.
- The emotional cost is high: anxiety and depression are common and deserve attention at each visit.
Next step / Initial management
- Refer to a gynaecologist or a recurrent loss clinic after two or more losses, sooner if she is older or has second-trimester losses.
- APS confirmed: plan aspirin and heparin from early pregnancy with a high-risk obstetric team.
- Parental rearrangement: refer to clinical genetics.
- Next pregnancy: early ultrasound for reassurance and care in an early pregnancy unit.
- Offer psychological support to both partners.
Common traps
- Normal results mean something was missed: up to half of couples have no cause, and that is a common and hopeful result, not a failed workup.
- Every woman with losses should be tested for inherited thrombophilias: their link to early loss is weak; antiphospholipid antibodies are what change treatment.
- One positive antiphospholipid test confirms APS: antibodies must persist on a repeat test at least 12 weeks later, because infections cause transient positives.
- Recurrent loss is mostly a chromosome problem in the parents: parental rearrangements are found in only a minority; most single losses are chance errors in the embryo.
Test yourself
Think of the answer, then tap the question to see it.
Why are antiphospholipid antibodies repeated at least 12 weeks after a positive result?
Infections and other illnesses can cause transient antibodies; APS needs antibodies that persist.
Which uterine anomaly is most linked to recurrent loss, and how is it treated?
A septate uterus; the septum can be removed by hysteroscopy.
When is karyotyping of both parents most useful?
When the tissue from a loss shows an unbalanced chromosomal rearrangement, or the tissue could not be tested.
What is the treatment for recurrent loss due to antiphospholipid syndrome?
Low-dose aspirin with heparin during pregnancy, managed by a high-risk obstetric team.
Elsewhere in DurgiPedia
- Spontaneous abortion: pathology
- Meiosis and nondisjunction: where trisomies come from
- Preconception care: risk review, family history, supplements, vaccines and planning a pregnancy
Connections
See it in 3D4
The structures of Durgical's 3D anatomy where it is found.
In Pharmacology2
← All of obstetrics and gynaecology
Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.
Sources: Recurrent Pregnancy Loss (StatPearls Publishing (NCBI Bookshelf), 2023); Antiphospholipid Syndrome (StatPearls Publishing (NCBI Bookshelf), 2024); Early Pregnancy Loss (Spontaneous Abortion) (StatPearls Publishing (NCBI Bookshelf), 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
